Joseph J. Larosa, EVP General Counsel and Secret at REGENERON PHARMACEUTICALS, INC. (REGN), sold 3,732 shares at $1088.95 ($4.1M) on 2024-07-11, disclosed to the SEC on 2024-07-12.
Scheduled sale ($4.1M) by EVP General Counsel and Secret under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1088.95 | 1,866 | $2.0M | 50.0% |
| 2 | $1088.95 | 1,866 | $2.0M | 50.0% |
| Total | $1088.95 avg | 3,732 | $4.1M | 100% |
| Filing → |
| REGN | SELL | 2024-02-26 | $968K | — | Filing → |
| REGN | SELL | 2024-02-09 | $950K | — | Filing → |
| REGN | SELL | 2022-04-11 | $7.4M | — | Filing → |